As of 18 Sept 2026, Orchid Pharma Ltd share price is ₹960.40. The stock opened at ₹960.40 and had closed at ₹957.60 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹471.30 and a high of ₹1,130.00. In terms of performance, Orchid Pharma Ltd share price has increased by 77.83% over the past six months and has increased by 21.44% over the last year.
ORCHPHARMA Stock Price Chart
Orchid Pharma Ltd Overview
About ORCHPHARMA
Orchid Pharma 01 the leading ptlarrna<;eutlcal oompanies in India haad quartered In Channai and Involved in the davelopment, manufacture and marketing of diverse bulk aeWes. formulationS and nutraceu~cals with exports spanning over 40 counllies. Orcttid's world class manufacturing infrasl1uclure Include USFDA compliant API and Finished Dosage Form faciliUes at Chennai In India. OrctIid lias dediCilted stale-of-art and GLP compliant R&D infrastructure fOf Procen researetl, Drug Discovery and Pllarmaceut!cal researen at Chennal, India.
Orchid Pharma Ltd Historical Performance
Orchid Pharma Ltd Fundamentals
Orchid Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,289.27 | 953.86 | 849.76 | 685.33 | 565.97 |
| EBITDA | 86.94 | 155.46 | 141.07 | 142.27 | 66.26 |
| Net Profit | 34.62 | 106.48 | 94.75 | 54.19 | -4.81 |
| EPS | 5.78 | 20.99 | 19.59 | 13.28 | -1.18 |
Orchid Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 943.68 |
| Resistance 1 (R1) | 979.83 |
| Pivot Point | 965.92 |
ORCHPHARMA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| R G Agarwal | Chairman |
| Manish Dhanuka | Managing Director |
| Mridul Dhanuka | E D & Wholetime Directorector |
Orchid Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Orchid Pharma Ltd today is ₹960.40 on NSE and ₹960.40 on BSE.
- The 52-week high of Orchid Pharma Ltd is ₹1,130.00, while the 52-week low is ₹471.30.
- The current market capitalisation of Orchid Pharma Ltd is approximately ₹5,735 crore.
- The P/E (Price-to-Earnings) ratio of Orchid Pharma Ltd is 151.76. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Orchid Pharma Ltd is 2.25. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Orchid Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ORCHPHARMA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Orchid Pharma Ltd has delivered a return of approximately 80.46%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Orchid Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 69.84% promoters, -19.12% FIIs, 20.75% DIIs, and 6.21% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
